My watch list
my.bionity.com  
Login  

Vaccines

Companies Vaccines

SIRION BIOTECH GmbH, Germany

SIRION Biotech is Europe's leading commercial supplier of viral vectors used for genetic cell modelling, gene target validation and gene therapy- and vaccination studies. Since its foundation in 2007, SIRION’s mission has been to change the paradigm for viral vector supplies. It has the ability to more

Richter-Helm BioLogics GmbH & Co. KG, Germany

Richter-Helm is a Hamburg, Germany-based contract development and manufacturing company specialized in products derived from bacteria and yeasts, with a proven 25-year track record. Count on us to flexibly provide a comprehensive range of services and customized solutions. Clients worldwide have al more

CureVac AG, Germany

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 18 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body t more

All companies on vaccines

News Vaccines

  • CureVac Initiates Phase 2a Clinical Trial of COVID-19 Vaccine Candidate

    CureVac N.V. announced that the first participant has been dosed in a Phase 2a clinical trial of its COVID-19 vaccine candidate, CVnCoV. The dose-confirmation study, entitled CV-NCOV-002, is being conducted in Peru and Panama and will enroll a total of 690 healthy participants in two distinct groups more

  • Spin-off project successfully developed a COVID-19 vaccine candidate

    With the current pandemic crisis, the lack of worldwide vaccine manufacturing capacity has become a serious concern. ContiVir, a spin-off project at the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has successfully produced a virus-like particle as a COVID-19 vaccine can more

  • BioNTech and Pfizer test COVID-19 Vaccine Candidate in Germany

    BioNTech SE and Pfizer Inc. announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 2/3 clinical trial in Germany for their BNT162b2 vaccine candidate. The study in Germany is part of the global pivotal Phase 2/3 program BioNTech and Pfizer initiated in July more

All news on vaccines

White papers Vaccines

Infographics Vaccines

A Summary of Common Vaccine Components

The recent measles outbreak in the US has once again provoked discussion over vaccinations, and why some parents choose not to vaccinate their children despite the benefits of doing so. Whilst not the only factor, part of the blame lies with misinformation about the chemical composition of vaccines more

Publications Vaccines

All publications on vaccines
Definition

Timeline of vaccines

Timeline of vaccines This is a timeline of the development of prophylactic human vaccine s. Early vaccines may be listed by the first year of development or testing, but later entries usually show the year the vaccine finished trials and became ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE